Shenzhen New Industries Biomedical's Attributable Profit Rises 13% in H1; Shares Rise 4%

MT Newswires Live

Aug 14

Shenzhen New Industries Biomedical Engineering's (SHE:300832) attributable profit rose 13% to 867.7 million yuan in the first half from 771.1 million yuan in the year-ago period, according to a Friday filing with the Shenzhen Stock Exchange.

Earnings per share at the clinical laboratory instrument manufacturer increased to 1.1057 yuan from 0.9814 yuan in the prior-year period.

Operating revenue grew 11% year over year to 2.42 billion yuan from 2.18 billion yuan.

Shares rose 4% during afternoon trading on Friday.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers HK | Online Trading in stocks, bonds & ETFS","description":"Discover Tiger Brokers HK, an online trading platform for stocks&ETFs, options&futures, bonds and crypto. Open an account to enjoy low commission trading today!","keywords":"tiger trading,tiger security,tiger broker hk,tigers co ltd,tiger trade hk,tiger brokers hk,stock broker,securities broker,online brokerage,hong kong broker,hk broker,online stock trading,online trading platform,stock trading platforms,trading application,stock trading,stock trading hong kong,buying stocks in hong kong,tiger brokers","social":{"ogDescription":"Discover Tiger Brokers HK, an online trading platform for stocks&ETFs, options&futures, bonds and crypto. Open an account to enjoy low commission trading today!","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.gotigerhk.com/news/2659956118"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"HKG","license":"TBHK","edition":"fundamental"},"isCrawlerRequest":true,"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"2659956118\",edition:\"fundamental\",auth_exemption:1,,,undefined,":{"share":"https://ttm.financial/m/news/2659956118?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2026-08-14 13:50","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2659956118","market":"nz","top_or_hot":-1,"title":"Shenzhen New Industries Biomedical's Attributable Profit Rises 13% in H1; Shares Rise 4%","media":"MT Newswires Live","content":"<html><body><p> <a href=\"https://laohu8.com/S/300832\">Shenzhen New</a> Industries Biomedical Engineering's (SHE:300832) attributable profit rose 13% to 867.7 million yuan in the first half from 771.1 million yuan in the year-ago period, according to a Friday filing with the Shenzhen Stock Exchange.</p><p>Earnings per share at the clinical laboratory instrument manufacturer increased to 1.1057 yuan from 0.9814 yuan in the prior-year period.</p><p>Operating revenue grew 11% year over year to 2.42 billion yuan from 2.18 billion yuan.</p><p>Shares rose 4% during afternoon trading on Friday.</p></body></html>","source":"mtnewswires_news","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Shenzhen New Industries Biomedical's Attributable Profit Rises 13% in H1; Shares Rise 4%</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nShenzhen New Industries Biomedical's Attributable Profit Rises 13% in H1; Shares Rise 4%\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1092851196\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/3002d84abbd5ace3c99397c7f95b8d4e);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">MT Newswires Live </p>\n<p class=\"h-time\">2026-08-14 13:50</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<html><body><p> <a href=\"https://laohu8.com/S/300832\">Shenzhen New</a> Industries Biomedical Engineering's (SHE:300832) attributable profit rose 13% to 867.7 million yuan in the first half from 771.1 million yuan in the year-ago period, according to a Friday filing with the Shenzhen Stock Exchange.</p><p>Earnings per share at the clinical laboratory instrument manufacturer increased to 1.1057 yuan from 0.9814 yuan in the prior-year period.</p><p>Operating revenue grew 11% year over year to 2.42 billion yuan from 2.18 billion yuan.</p><p>Shares rose 4% during afternoon trading on Friday.</p></body></html>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"300832","symbol_name":"新产业","start_time":0,"source_url":"https://www.mtnewswires.com/","article_id":"2659956118","we_media_id":"1092851196","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2659956118","pubTimestamp":1786686608,"columns":[],"sourceInfo":{"source_id":"mtnewswires_news","name":"MT Newswires"},"weMediaInfo":{"media_name":"MT Newswires Live","introduction":"The most recognized names in North America, Europe and Asia rely on MT Newswires to power their applications. Better news, better service, better price.","home_visible":1,"id":"1092851196","head_image":"https://community-static.tradeup.com/news/3002d84abbd5ace3c99397c7f95b8d4e"},"summary":"Shenzhen New Industries Biomedical Engineering's  attributable profit rose 13% to 867.7 million yuan in the first half from 771.1 million yuan in the year-ago period, according to a Friday filing with the Shenzhen Stock Exchange.Earnings per share at the clinical laboratory instrument manufacturer increased to 1.1057 yuan from 0.9814 yuan in the prior-year period.Operating revenue grew 11% year over year to 2.42 billion yuan from 2.18 billion yuan.Shares rose 4% during afternoon trading on Friday.","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"300832":"新产业","BK0239":"医药制造","FCA":"First Trust China AlphaDEX Fund"},"translate_title":"深圳新产业生物医药上半年应占利润增长13%；股价上涨 4%","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"300832":0.9,"FCA":0.9},"content_text":"Shenzhen New Industries Biomedical Engineering's (SHE:300832) attributable profit rose 13% to 867.7 million yuan in the first half from 771.1 million yuan in the year-ago period, according to a Friday filing with the Shenzhen Stock Exchange.Earnings per share at the clinical laboratory instrument manufacturer increased to 1.1057 yuan from 0.9814 yuan in the prior-year period.Operating revenue grew 11% year over year to 2.42 billion yuan from 2.18 billion yuan.Shares rose 4% during afternoon trading on Friday.","kind":"highlight","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":true,"editions":null,"column":"","sentiment":"1","news_tag":"dataReport","news_rank":0,"isVideo":false,"video":null,"symbols":[],"gpt_button":1,"need_auth":false,"need_login_tip":false,"code":"91000000","status":"200"}}}